M.G. Smola

747 total citations
24 papers, 487 citations indexed

About

M.G. Smola is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, M.G. Smola has authored 24 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 8 papers in Cancer Research. Recurrent topics in M.G. Smola's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). M.G. Smola is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). M.G. Smola collaborates with scholars based in Austria, Germany and Italy. M.G. Smola's co-authors include E. Scharnagl, H. Peter Soyer, Luigi Cataliotti, N. J. O’Higgins, M Blichert-Toft, Marianne Schmid, Andreas Salat, R. Jakesz, M. Stierer and Michael Gnant and has published in prestigious journals such as Cancer, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

M.G. Smola

24 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.G. Smola Austria	10	233	145	132	117	78	24	487
Donatella Gambini Italy	16	300 1.3×	170 1.2×	111 0.8×	147 1.3×	81 1.0×	48	611
Salwa Sheikh Saudi Arabia	16	271 1.2×	152 1.0×	195 1.5×	113 1.0×	54 0.7×	47	690
Rouzan G. Karabakhtsian United States	13	180 0.8×	117 0.8×	221 1.7×	181 1.5×	34 0.4×	34	599
R. Knight United Kingdom	15	367 1.6×	134 0.9×	118 0.9×	275 2.4×	25 0.3×	32	642
F. Mayall United Kingdom	16	212 0.9×	363 2.5×	142 1.1×	80 0.7×	63 0.8×	39	693
Michael S. Ballo United States	11	204 0.9×	111 0.8×	129 1.0×	96 0.8×	26 0.3×	19	584
Linda M. Sanders United States	11	126 0.5×	61 0.4×	206 1.6×	59 0.5×	30 0.4×	33	389
H Ehya United States	13	196 0.8×	175 1.2×	165 1.3×	133 1.1×	17 0.2×	21	603
Charles D. Callery United States	8	266 1.1×	148 1.0×	82 0.6×	48 0.4×	33 0.4×	14	457
Merrick I. Ross United States	11	322 1.4×	150 1.0×	153 1.2×	155 1.3×	26 0.3×	15	609

Countries citing papers authored by M.G. Smola

Since Specialization

Citations

This map shows the geographic impact of M.G. Smola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Smola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Smola more than expected).

Fields of papers citing papers by M.G. Smola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Smola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Smola. The network helps show where M.G. Smola may publish in the future.

Co-authorship network of co-authors of M.G. Smola

This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Smola. A scholar is included among the top collaborators of M.G. Smola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Smola. M.G. Smola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merli, Dominik, et al.. (2013). Comprehensive Analysis of Software Countermeasures against Fault Attacks. Design, Automation & Test in Europe Conference & Exhibition (DATE), 2013. 404–409. 9 indexed citations

Merli, Dominik, et al.. (2013). Comprehensive analysis of software countermeasures against fault attacks. 404–409. 12 indexed citations

Koch, Horst, et al.. (2004). Verrucous Carcinoma of the Skin: Long-Term Follow-up Results Following Surgical Therapy. Dermatologic Surgery. 30(8). 1124–1130. 23 indexed citations

Koch, Horst, et al.. (2004). Verrucous Carcinoma of the Skin. Dermatologic Surgery. 30(8). 1124–1130. 1 indexed citations

Thalhammer, M., L Kronberger, Peter Regitnig, et al.. (2001). Sentinel lymph node biopsy and axillary dissection in breast cancer: results and initial experience of a changed technique with subareolar intradermal blue dye injection only. European Journal of Cancer. 37. S180–S181. 1 indexed citations

Kronberger, L, Peter M. Liebmann, Hans Rabl, et al.. (2000). Selective Decrease of Serum Immunoglobulin G1 as Marker for Early Stages of Invasive Breast Cancer. Breast Cancer Research and Treatment. 64(2). 193–199. 5 indexed citations

O’Higgins, N. J., Dimitrios Linos, M Blichert-Toft, et al.. (1998). European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group.. PubMed. 87(1). 110–2. 16 indexed citations

O’Higgins, N. J., M Blichert-Toft, Luigi Cataliotti, et al.. (1998). European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Journal of Surgical Oncology. 24(2). 96–98. 37 indexed citations

Häuser, H., et al.. (1997). Experience with a high speed biopsy gun in breast cancer diagnosis. European Journal of Surgical Oncology. 23(3). 206–207. 4 indexed citations

10.

Blichert-Toft, M, M.G. Smola, Luigi Cataliotti, & N. J. O’Higgins. (1997). Principles and guidelines for surgeons—management of symptomatic breast cancer. European Journal of Surgical Oncology. 23(2). 101–109. 38 indexed citations

11.

Klimpfinger, M., et al.. (1997). Probleme der intraoperativen Schnellschnittdiagnostik von Mammaläsionen — Analyse von 5479 konsekutiven Fällen. European surgery. Supplement/European surgery. 29(3). 123–125. 1 indexed citations

12.

Bauernhofer, Thomas, Herbert Stöger, Marianne Schmid, et al.. (1996). Sequential treatment of recurrent mesenteric desmoid tumor. Cancer. 77(6). 1061–1065. 6 indexed citations

13.

Bauernhofer, Thomas, Herbert Stöger, M.G. Smola, et al.. (1996). Sequential treatment of recurrent mesenteric desmoid tumor. Cancer. 77(6). 1061–1065. 56 indexed citations

14.

Smola, M.G.. (1993). Prognostic factors of soft tissue sarcomas. European surgery. Supplement/European surgery. 25(4). 241–245. 7 indexed citations

15.

Smola, M.G., Manfred Ratschek, W. Amann, H. Samonigg, & Ramona Mayer. (1993). The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature.. PubMed. 19(1). 61–9. 20 indexed citations

16.

Lind, P., M.G. Smola, P. Lechner, et al.. (1991). The immunoscintigraphic use of Tc‐99m‐labelled monoclonal anti‐CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. International Journal of Cancer. 47(6). 865–869. 27 indexed citations

17.

Samonigg, Hellmut, Marianne Schmid, Karl Pfeiffer, et al.. (1991). Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer. Cancer Chemotherapy and Pharmacology. 27(6). 477–480. 4 indexed citations

18.

Smola, M.G., et al.. (1991). ΣS, a measure of reactive sulfur groups of immunoglobulin G, is a sensitive tumor marker discriminating different stages of breast cancer. Cancer. 68(5). 1026–1030. 8 indexed citations

19.

Samonigg, Hellmut, Herbert Stöger, Marianne Schmid, et al.. (1990). 4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 26(4). 293–296. 7 indexed citations

20.

Hellbom, B., et al.. (1986). [Compartment syndrome as a complication of surgical position in penis replantation].. PubMed. 18(6). 363–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact